Abbott Laboratories (ABT) Stock News

Abbott (ABT) announced plans to spin off its Nutrition business into a new publicly traded company via a tax-free distribution to shareholders. The Nutrition unit, with ~$8.5B in annual sales and brands like Similac and Ensure, will operate independently. Abbott will focus on its higher-growth medtech and diagnostics portfolio (~$42B sales). Completion expected by end of 2027, subject to approvals.

Abbott (ABT) introduced a new protein powder that combines protein, creatine, and HMB in one scoop. The product is aimed at adults seeking muscle support for active lifestyles, not just athletes. Available at Walmart and Amazon.

Abbott Laboratories has agreed to pay $385 million to resolve claims from the U.S. Department of Justice and several states over poor manufacturing practices at two facilities, including its Sturgis, Michigan infant formula plant. The settlement includes $348.7 million under the False Claims Act and $36.3 million to states, with no admission of fault or liability.